191 related articles for article (PubMed ID: 6530392)
1. Thrombin-inhibitory activity of whale heparin oligosaccharides.
Ototani N; Kodama C; Kikuchi M; Yosizawa Z
J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
[TBL] [Abstract][Full Text] [Related]
2. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
Ototani N; Kikuchi M; Yosizawa Z
Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activities for thrombin and factor Xa of whale heparin: comparative studies on two preparations from different species.
Ototani N; Yosizawa Z
Tohoku J Exp Med; 1986 Sep; 150(1):77-82. PubMed ID: 3775773
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
[TBL] [Abstract][Full Text] [Related]
5. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant activity of heparin octasaccharide.
Ototani N; Yosizawa Z
J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
[TBL] [Abstract][Full Text] [Related]
7. Activation of heparin cofactor II by heparin oligosaccharides.
Maimone MM; Tollefsen DM
Biochem Biophys Res Commun; 1988 May; 152(3):1056-61. PubMed ID: 3377765
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
Nagasawa K; Uchiyama H
J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
[TBL] [Abstract][Full Text] [Related]
9. Sulfated oligosaccharides isolated from the deamination products of heparins.
Kosakai M; Yosizawa Z
J Biochem; 1981 Jun; 89(6):1933-44. PubMed ID: 6270073
[TBL] [Abstract][Full Text] [Related]
10. Heparinase II from Flavobacterium heparinum. HPLC analysis of the saccharides generated from chemically modified heparins.
Moffat CF; McLean MW; Long WF; Williamson FB
Eur J Biochem; 1991 Dec; 202(2):531-41. PubMed ID: 1761054
[TBL] [Abstract][Full Text] [Related]
11. Structure determination of the octa- and decasaccharide sequences isolated from the carbohydrate-protein linkage region of porcine intestinal heparin.
Sugahara K; Tsuda H; Yoshida K; Yamada S; de Beer T; Vliegenthart JF
J Biol Chem; 1995 Sep; 270(39):22914-23. PubMed ID: 7559427
[TBL] [Abstract][Full Text] [Related]
12. Contribution of chemical 6-O-sulfation of the aminodeoxyhexose residues in whale heparin with high affinity for antithrombin III to its anticoagulant properties.
Uchiyama H; Metori A; Ogamo A; Nagasawa K
J Biochem; 1990 Mar; 107(3):377-80. PubMed ID: 2341372
[TBL] [Abstract][Full Text] [Related]
13. Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates.
Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugahara K; Khoo KH; Morris HR; Dell A
Glycobiology; 1994 Feb; 4(1):69-78. PubMed ID: 8186552
[TBL] [Abstract][Full Text] [Related]
14. Search for the heparin antithrombin III-binding site precursor.
Linhardt RJ; Wang HM; Loganathan D; Bae JH
J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
Ototani N; Kikuchi M; Yosizawa Z
J Biochem; 1981 Jul; 90(1):241-6. PubMed ID: 7287679
[TBL] [Abstract][Full Text] [Related]
16. Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin.
Yamada S; Yoshida K; Sugiura M; Sugahara K; Khoo KH; Morris HR; Dell A
J Biol Chem; 1993 Mar; 268(7):4780-7. PubMed ID: 8444855
[TBL] [Abstract][Full Text] [Related]
17. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
Danielsson A; Raub E; Lindahl U; Björk I
J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
[TBL] [Abstract][Full Text] [Related]
18. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of guinea pig antithrombin III.
Heck L; Rosenberg R; Remold H
Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
Toida T; Hileman RE; Smith AE; Vlahova PI; Linhardt RJ
J Biol Chem; 1996 Dec; 271(50):32040-7. PubMed ID: 8943254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
